Related Experiment Video
Updated: May 11, 2026

Double Direct Injection of Blood into the Cisterna Magna as a Model of Subarachnoid Hemorrhage
Published on: August 30, 2020
Nonaneurysmal subarachnoid hemorrhage after udenafil intake
Eun-Kee Bae1, Jong-Hyeon Ahn, Jeong-Jin Park
1Department of Neurology, Inha University Hospital, Incheon, Korea.
Phosphodiesterase 5 inhibition may trigger perimesencephalic subarachnoid hemorrhage. This rare event may be linked to venous hypertension, potentially associated with vein of Galen stenosis.
Area of Science:
- Neurology
- Pharmacology
Background:
- Phosphodiesterase 5 (PDE5) inhibitors are widely used for erectile dysfunction.
- Severe headache is a potential side effect of PDE5 inhibitors.
Observation:
- A 67-year-old man experienced a severe headache after taking 50 mg of udenafil, a novel PDE5 inhibitor.
- Brain CT revealed acute subarachnoid hemorrhage in the basal cisterns.
Findings:
- No cerebral artery aneurysms were identified.
- Magnetic resonance venography suggested possible vein of Galen stenosis.
- The subarachnoid hemorrhage was localized anterior to the midbrain and pons.
Implications:
- This case suggests a potential link between PDE5 inhibition and perimesencephalic subarachnoid hemorrhage.
- Venous hypertension, possibly due to vein of Galen stenosis, may be a contributing factor.
- Further research is needed to confirm the association between PDE5 inhibitors and this type of hemorrhage.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Hemorrhagic Stroke l: Introduction
Aneurysm III: Interprofessional Care
Aneurysm IV: Nursing Management
Aneurysm I: Introduction
Aneurysm II: Clinical Manifestations and Diagnostic Studies
